Humoral Immunogenicity of Three COVID-19 mRNA Vaccine Doses in Patients with Inflammatory Bowel Disease

  1. Trevor L. Schell
  2. Keith L. Knutson
  3. Sumona Saha
  4. Arnold Wald
  5. Hiep S Phan
  6. Mazen Almasry
  7. Kelly Chun
  8. Ian Grimes
  9. Megan Lutz
  10. Mary S. Hayney
  11. Francis A. Farraye
  12. Freddy Caldera
1 evaluations Published on
Read the full article Related papers
This article on Sciety

Abstract

Herein, we evaluated the humoral immunogenicity of a third COVID-19 mRNA vaccine dose in patients with IBD. All patients were seropositive and had higher antibody concentrations after the third dose than after completion of the two-dose primary series.

Related articles

Related articles are currently not available for this article.